(Q34337626)

1 August 2017

title

PML-mediated signaling and its role in cancer stem cells (English)

1 reference

1 August 2017

main subject

neoplastic stem cells

1 reference

W Zhou

1

1 reference

1 August 2017

S Bao

series ordinal

2

1 reference

1 August 2017

language of work or name

English

0 references

publication date

8 April 2013

1 reference

1 August 2017

1 reference

1 August 2017

volume

33

1 reference

1 August 2017

issue

12

1 reference

1 August 2017

page(s)

1475-1484

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2013.111

1 August 2017

exact match

0 references

cites work

The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Characterization of a Zinc Finger Gene Disrupted by the t(15;17) in Acute Promyelocytic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Acute promyelocytic leukaemia: novel insights into the mechanisms of cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

PML targeting eradicates quiescent leukaemia-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

PML protein isoforms and the RBCC/TRIM motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

TRIM proteins and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Characterization of endogenous human promyelocytic leukemia isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

PML is a direct p53 target that modulates p53 effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Interleukin 6 signaling regulates promyelocytic leukemia protein gene expression in human normal and cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Covalent modification of PML by the sentrin family of ubiquitin-like proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Identification of three major sentrinization sites in PML

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Differential regulation of sentrinized proteins by a novel sentrin-specific protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

SUMO-1 protease-1 regulates gene transcription through PML

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

SUSP1 antagonizes formation of highly SUMO2/3-conjugated species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

A CK2-dependent mechanism for degradation of the PML tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Arsenic-induced SUMO-dependent recruitment of RNF4 into PML nuclear bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

E6AP promotes the degradation of the PML tumor suppressor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

A Cullin3-KLHL20 Ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Mitogen-activated protein kinase extracellular signal-regulated kinase 2 phosphorylates and promotes Pin1 protein-dependent promyelocytic leukemia protein turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Size, position and dynamic behavior of PML nuclear bodies following cell stress as a paradigm for supramolecular trafficking and assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

The mechanisms of PML-nuclear body formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

A role for PML and the nuclear body in genomic stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

PML-RARA can increase hematopoietic self-renewal without causing a myeloproliferative disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Role of PML in cell growth and the retinoic acid pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

A metabolic prosurvival role for PML in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Nuclear and chromatin reorganization in the MHC-Oct3/4 locus at developmental phases of embryonic stem cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Retinoic acid-stimulated sequential phosphorylation, PML recruitment, and SUMOylation of nuclear receptor TR2 to suppress Oct4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

SUMOylation of Tr2 orphan receptor involves Pml and fine-tunes Oct4 expression in stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Opposing effects of PML and PML/RAR alpha on STAT3 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Nontelomeric TRF2-REST interaction modulates neuronal gene silencing and fate of tumor and stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

c-Myc localization within the nucleus: evidence for association with the PML nuclear body

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Promyelocytic leukemia protein in retinoic acid-induced chromatin remodeling of Oct4 gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Changing nuclear landscape and unique PML structures during early epigenetic transitions of human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

The tumor suppressor Pml regulates cell fate in the developing neocortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phases in immortalized telomerase-negative cells. Implication of NBS1 in alternative lengthening of telomeres

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Regulation and localization of the Bloom syndrome protein in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

PML colocalizes with and stabilizes the DNA damage response protein TopBP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

ATR kinase activity regulates the intranuclear translocation of ATR and RPA following ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Sumoylation of the novel protein hRIP{beta} is involved in replication protein A deposition in PML nuclear bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Promyelocytic leukemia nuclear bodies behave as DNA damage sensors whose response to DNA double-strand breaks is regulated by NBS1 and the kinases ATM, Chk2, and ATR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Alternative lengthening of telomeres in human glioma stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

De novo assembly of a PML nuclear subcompartment occurs through multiple pathways and induces telomere elongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Localization of hRad9, hHus1, hRad1, and hRad17 and caffeine-sensitive DNA replication at the alternative lengthening of telomeres-associated promyelocytic leukemia body

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Telomeric DNA mediates de novo PML body formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Nucleostemin prevents telomere damage by promoting PML-IV recruitment to SUMOylated TRF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Role of PML and PML-RARalpha in Mad-mediated transcriptional repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

The promyelocytic leukemia protein represses A20-mediated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Sequestration and inhibition of Daxx-mediated transcriptional repression by PML

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Regulation of Pax3 transcriptional activity by SUMO-1-modified PML

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

PML promotes MHC class II gene expression by stabilizing the class II transactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Dual functions of histone-lysine N-methyltransferase Setdb1 protein at promyelocytic leukemia-nuclear body (PML-NB): maintaining PML-NB structure and regulating the expression of its associated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

PML is essential for multiple apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

PML induces a novel caspase-independent death process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Nuclear and cytoplasmic shuttling of TRADD induces apoptosis via different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Cytoplasmic PML function in TGF-beta signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Promyelocytic leukemia protein sensitizes tumor necrosis factor alpha-induced apoptosis by inhibiting the NF-kappaB survival pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Promyelocytic leukemia is a direct inhibitor of SAPK2/p38 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

IFN-alpha-induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independently of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

SUMOylation-dependent localization of IKKepsilon in PML nuclear bodies is essential for protection against DNA-damage-triggered cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Regulation of p53 activity in nuclear bodies by a specific PML isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

The function of PML in p53-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

PML interaction with p53 and its role in apoptosis and replicative senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Promyelocytic leukemia protein is required for gain of function by mutant p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

MDM2 and Promyelocytic Leukemia Antagonize Each Other through Their Direct Interaction with p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

PML regulates p53 stability by sequestering Mdm2 to the nucleolus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Physical and functional interactions between PML and MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Identification of a tumour suppressor network opposing nuclear Akt function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

The eIF4E RNA regulon promotes the Akt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

PML regulates apoptosis at endoplasmic reticulum by modulating calcium release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Promyelocytic leukemia protein (PML) functions as a glucocorticoid receptor co-activator by sequestering Daxx to the PML oncogenic domains (PODs) to enhance its transactivation potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Daxx represses expression of a subset of antiapoptotic genes regulated by nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

ZIP kinase triggers apoptosis from nuclear PML oncogenic domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

PML regulates p53 acetylation and premature senescence induced by oncogenic Ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Deconstructing PML-induced premature senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Dynamic regulation of p53 subnuclear localization and senescence by MORC3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PML-induced senescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Downregulation of Wnt signaling is a trigger for formation of facultative heterochromatin and onset of cell senescence in primary human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Definition of pRB- and p53-dependent and -independent steps in HIRA/ASF1a-mediated formation of senescence-associated heterochromatin foci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Physical and functional interaction between PML and TBX2 in the establishment of cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Regulation of E2Fs and senescence by PML nuclear bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Cancer stem cell definitions and terminology: the devil is in the details.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Histone deacetylase inhibitors suppress IFNalpha-induced up-regulation of promyelocytic leukemia protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

The alternative lengthening of telomeres pathway may operate in non-neoplastic human cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Promyelocytic leukemia activates Chk2 by mediating Chk2 autophosphorylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

Regulation of PML-dependent transcriptional repression by pRB and low penetrance pRB mutants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.111

31 March 2020

Identifiers

DOI

10.1038/ONC.2013.111

1 reference

Dimensions Publication ID

1 August 2017

1036463501

0 references

1 reference